Domov › Rak jajčnikov › Maryland › Baltimore
Klinične študije za Rak jajčnikov v Baltimore, MD
22 študij za Rak jajčnikov išče udeležence na lokacijah v Baltimore in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Vključevanje udeležencevFaza 2/3
- University of Maryland/Greenebaum Cancer Center, Baltimore
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Vključevanje udeležencevFaza 2
- University of Maryland/Greenebaum Cancer Center, Baltimore
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 2
- Johns Hopkins University, Baltimore
Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer
Vključevanje udeležencevFaza 3
- Research Site, Baltimore
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Vključevanje udeležencevFaza 2
- University of Maryland, Baltimore /ID# 275308, Baltimore
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Vključevanje udeležencevFaza 3
- Greater Baltimore Medical Center, Baltimore
- Sinai Hospital Of Baltimore, Baltimore
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Vključevanje udeležencevFaza 1
- United Theranostics, Glen Burnie · 9 mi stran
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Vključevanje udeležencevFaza 2
- Greater Baltimore Medical Center, Baltimore
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Vključevanje udeležencevFaza 1/2
- Research Site, Baltimore
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
Vključevanje udeležencevFaza 3
- Greater Baltimore Medical Center, Towson · 8 mi stran
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Vključevanje udeležencevFaza 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Vključevanje udeležencevFaza 2
- The John Hopkins Hospital, Baltimore
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
Vključevanje udeležencevFaza 3
- University of Maryland, Baltimore
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Vključevanje udeležencevFaza 3
- Greater Baltimore Medical Center, Towson · 8 mi stran
EXoPERT EMERALD Clinical Study
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- John Hopkins University, Baltimore
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
Vključevanje udeležencevFaza 1
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Vključevanje udeležencevFaza 1
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Vključevanje udeležencevFaza 2
- SCRI - Maryland Oncology Hematology, P.A., Annapolis · 22 mi stran
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · 8 mi stran
Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
Vključevanje udeležencevFaza 2
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Vključevanje udeležencevOpazovalna študija
- Johns Hopkins University School of Medicine, Baltimore
- Anne Arundel Health System, Annapolis · 22 mi stran
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Vključevanje udeležencevFaza 1/2
- Johns Hopkins, Baltimore
Študije za Rak jajčnikov v drugih mestih
- Houston, TX89 študij
- New York City, NY69 študij
- Boston, MA61 študij
- Los Angeles, CA50 študij
- Nashville, TN49 študij
- Arlington, VA46 študij
- Philadelphia, PA44 študij
- Columbus, OH39 študij
- St. Louis, MO38 študij
- Chicago, IL36 študij
- San Antonio, TX31 študij
- Cleveland, OH30 študij
Druge študije v Baltimore
- Nemalicelični pljučni rak60 študij
- Rak dojke47 študij
- Rak prostate43 študij
- Rak pljuč40 študij
- Rak (vse vrste)37 študij
- Rak trebušne slinavke31 študij
- Kolorektalni rak31 študij
- Metastatski rak28 študij
- Debelost26 študij
- Rak mehurja24 študij
- Srčno popuščanje24 študij
- Možganska kap21 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.